PD receives funding support from the Princess Margaret Cancer Foundation, Ontario Institute for Cancer Research, Canadian Cancer Society Innovation Fund and The Terry Fox New Investigator Awards Program
A., Gleiberman, L., Harburg, E., DiFranceisco, W., & Schork, A
Safety: Preclinical studies showed no acute toxicity across organ systems and no evidence of mutagenicity or teratogenicity
The purpose of this review is to attempt to integrate evidence from different sources regarding (i) the enzyme(s) responsible for the initial conversion of -ketoglutarate to glutamate
Additional processes, including hydrogen bonding between the polysaccharide and the phospholipid head groups, may be also involved in the CS coating process [73]